CLX-006

N/A

Report date: 2023/07/10 17:58:47
NME

Base Information

Drug NameCLX-006
Drug Alias NameCLX-006CLX006
ClassificationSmall molecules
Mechanisms of ActionProtein-arginine N-methyltransferases inhibitors
TargetsProtein-arginine N-methyltransferases
Therapy Area/IndicationsLung NeoplasmsPancreatic NeoplasmsEsophageal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesCytosinLab Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCytosinLab Therapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsLung NeoplasmsPancreatic NeoplasmsEsophageal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A